Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

33.08 USD +0.11 (+0.33%)
Official Closing Price Updated: 7:01 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bausch Health Companies Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Solta Medical Announces the U.S. Launch of The Clear + Brilliant® Touch Laser
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its Solta Medical business, a global leader in the medical aesthetics market, today announced the U.S. launch of the Clear +... 
From PR Newswire
COLON CANCER COALITION AND SALIX LAUNCH A YEAR-LONG CAMPAIGN TO RAISE AWARENESS ABOUT COLORECTAL CANCER SCREENINGS
Tags h:worldnews s:minnesota c:united/states
From EIN Presswire
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $100 million through the redemption of outstanding senior secured notes, using... 
From PR Newswire
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance
From PR Newswire
Bausch Health Announces Agreement With Carl C. Icahn
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") is pleased to announce that it will expand its Board of Directors (the "Board") to add two designees to the Board from... 
From PR Newswire
Bausch + Lomb Launches Alaway® Preservative Free Antihistamine Eye Drops
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the U.S. launch of Alaway® Preservative Free (ketotifen fumarate... 
From PR Newswire
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $100 million through the redemption of outstanding senior secured notes, using... 
From PR Newswire
Salix Announces 2021 Gastrointestinal Health Scholars Program
Students Living with GI Disease Are Encouraged to Apply Through May 31, 2021 
From PR Newswire
Bausch Health Announces Participation In Upcoming Investor Conferences
Bausch Health Companies Inc. (NYSE: BHC, TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in three upcoming investor conferences. 
From PR Newswire
Bausch Health Responds To Schedule 13D Filing From Icahn Capital LP
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") issued the following statement in response to the Schedule 13D filed by Icahn Capital LP filed earlier today: 
From PR Newswire
Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved in South Korea
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), Bausch + Lomb, a leading global eye health business, and Nicox (Euronext Paris: FR0013018124, COX), an international... 
From PR Newswire
Bausch Health Announces Vyzulta® (latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved in South Korea
From GlobeNewswire News Releases
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting
From GlobeNewswire News Releases
Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Program
Students Living with Dermatologic Conditions Are Encouraged To Apply Through May 31, 2021 
From PR Newswire
Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD)
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Prevent Blindness, the nation's oldest volunteer eye health non-profit... 
From PR Newswire
Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its fourth-quarter and full-year 2020 financial results on Wednesday, Feb. 24, 2021. Bausch Health will host a conference... 
From PR Newswire
Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)
Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million) 
From Business Wire News Releases
South Korea's MFDS Approves LUMIFY® Eye Drops
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that LUMIFY® (brimonidine tartrate ophthalmic solution 0.025%)... 
From PR Newswire
Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that two poster presentations will feature data on the new Bausch... 
From PR Newswire
Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 (perfluorohexyloctane)
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), and Novaliq GmbH, a pharmaceutical company focusing on first- and... 
From PR Newswire
Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will provide a preliminary update on its fourth-quarter and full-year 2020 financial results and the continued pace of... 
From PR Newswire
Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to participate at the 39th Annual J.P. Morgan Healthcare Conference... 
From PR Newswire
Nicox’s Licensee Bausch + Lomb Launches VYZULTA in Mexico
From GlobeNewswire News Releases
Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland has granted an... 
From PR Newswire
Bausch Health To Reduce Debt By $275 Million
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that on Dec. 31, 2020 it will pay down an additional $275 million of its senior secured term loans using... 
From PR Newswire
Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") and Bausch + Lomb, its leading global eye health business, announced today that the Company has initiated the second of... 
From PR Newswire
Nicox’s Licensee Bausch + Lomb Launches VYZULTA in Argentina
From GlobeNewswire News Releases
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Conditional Redemption Of Additional Series Of Existing Senior Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced and upsized its previously announced offering of $1.0 billion aggregate principal... 
From PR Newswire
Bausch Health Announces Launch Of Private Offering Of Senior Notes And Conditional Redemption Of Existing Senior Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of a combined $1.75 billion aggregate principal amount of new senior... 
From PR Newswire
Clearside Biomedical Announces Data Presentations at the American Academy Ophthalmology (AAO) 2020 Annual Meeting and Publication on the Suprachoroidal Injection Procedure in Translational Vision Scie
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.